Poseida Therapeutics SG&A Expense (TTM) Trends

Poseida Therapeutics Inc (PSTX)

3.02 +0.01 (+0.33%) USD | NASDAQ | Jul 02, 16:00

3.04 +0.02 (+0.66%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
March 31, 2024	35.42M
December 31, 2023	37.43M
September 30, 2023	37.94M
June 30, 2023	39.24M
March 31, 2023	39.80M
December 31, 2022	37.54M
September 30, 2022	37.78M
June 30, 2022	37.46M
March 31, 2022	37.09M

Date	Value
December 31, 2021	35.92M
September 30, 2021	33.78M
June 30, 2021	31.17M
March 31, 2021	26.54M
December 31, 2020	23.02M
September 30, 2020	19.56M
June 30, 2020	17.10M
March 31, 2020	16.91M
December 31, 2019	18.46M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

16.91M

Minimum

Mar 2020

39.80M

Maximum

Mar 2023

31.23M

Average

35.67M

Median

SG&A Expense (TTM) Benchmarks